139 related articles for article (PubMed ID: 20503106)
1. Vascular endothelial growth factor antisense oligonucleotides inhibit leptomeningeal metastasis in vivo.
Li K; Zhang G; Zhao J; Wang X; Li Y; Hu Y
Med Oncol; 2011 Dec; 28(4):1116-22. PubMed ID: 20503106
[TBL] [Abstract][Full Text] [Related]
2. Combination of vascular endothelial growth factor antisense oligonucleotide therapy and radiotherapy increases the curative effects against maxillofacial VX2 tumors in rabbits.
Zheng LF; Li YJ; Wang H; Zhao JL; Wang XF; Hu YS; Zhang GX
Eur J Radiol; 2011 May; 78(2):272-6. PubMed ID: 21193276
[TBL] [Abstract][Full Text] [Related]
3. Studies of pathology and VEGF expression in rabbit cerebrospinal fluid metastasis: application of dynamic contrast-enhanced MRI.
Li KA; Zhang RM; Zhang F; Zhao JL; Li YJ; Wang XF; Zheng LF; Hu YS; Zhang GX
Magn Reson Imaging; 2011 Oct; 29(8):1101-9. PubMed ID: 21868183
[TBL] [Abstract][Full Text] [Related]
4. Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivo.
Riedel F; Götte K; Li M; Hörmann K; Grandis JR
Int J Oncol; 2003 Sep; 23(3):577-83. PubMed ID: 12888890
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic therapy of head and neck squamous cell carcinoma by vascular endothelial growth factor antisense therapy.
Riedel F; Götte K; Hörmann K; Grandis JR
Adv Otorhinolaryngol; 2005; 62():103-20. PubMed ID: 15608422
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of 2'-o-methoxyethyl-modified antisense oligonucleotides targeting vascular endothelial growth factor A on SKOV3 human ovarian cancer cells.
Fu YB; Wen ZQ; Zhao XB; Yan L; Zhang CH; Wang F
Chin Med J (Engl); 2011 May; 124(10):1573-5. PubMed ID: 21740819
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hemangioma by transfection of antisense VEGF gene.
Shan S; Shan G; Zhang D
J Huazhong Univ Sci Technolog Med Sci; 2009 Jun; 29(3):335-9. PubMed ID: 19513617
[TBL] [Abstract][Full Text] [Related]
8. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
Xiong J; Yang Q; Li J; Zhou S
Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
[TBL] [Abstract][Full Text] [Related]
9. The toxicity of intrathecal bevacizumab in a rabbit model of leptomeningeal carcinomatosis.
Brastianos PK; Brastianos HC; Hsu W; Sciubba DM; Kosztowski T; Tyler BM; Recinos VR; Burger P; Grossman SA
J Neurooncol; 2012 Jan; 106(1):81-8. PubMed ID: 21789699
[TBL] [Abstract][Full Text] [Related]
10. A small interfering RNA targeting vascular endothelial growth factor efficiently inhibits growth of VX2 cells and VX2 tumor model of hepatocellular carcinoma in rabbit by transarterial embolization-mediated siRNA delivery.
Zou Y; Guo CG; Yang ZG; Sun JH; Zhang MM; Fu CY
Drug Des Devel Ther; 2016; 10():1243-55. PubMed ID: 27069355
[TBL] [Abstract][Full Text] [Related]
11. [The effect of VEGF antisense oligonucleotides combined with low molecular weight heparin on the growth and metastasis of mice Lewis lung cancer].
Zhang YH; Wang C; Pang BS; Zhai ZG; Weng XZ
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(11):749-52. PubMed ID: 16681948
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor antisense oligodeoxynucleotides with lipiodol in arterial embolization of liver cancer in rats.
Wu HP; Feng GS; Liang HM; Zheng CS; Li X
World J Gastroenterol; 2004 Mar; 10(6):813-8. PubMed ID: 15040023
[TBL] [Abstract][Full Text] [Related]
13. [VEGF antisense oligonucleotide inhibits the expression of vascular endothelial growth factor in human leukemic cell lines].
Zhang L; Tu ZG; Feng WL; Huang ZG
Zhonghua Xue Ye Xue Za Zhi; 2004 Jan; 25(1):22-5. PubMed ID: 14990072
[TBL] [Abstract][Full Text] [Related]
14. EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migration.
Riedel F; Götte K; Li M; Hörmann K; Grandis JR
Int J Oncol; 2002 Jul; 21(1):11-6. PubMed ID: 12063543
[TBL] [Abstract][Full Text] [Related]
15. Abrogation of TGF-beta by antisense oligonucleotides modulates expression of VEGF and increases angiogenic potential in isolated fibroblasts from radiated skin.
Riedel K; Koellensperger E; Ryssel H; Riedel F; Goessler UR; Germann G; Kremer T
Int J Mol Med; 2008 Oct; 22(4):473-80. PubMed ID: 18813854
[TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
Ciardiello F; Bianco R; Damiano V; Fontanini G; Caputo R; Pomatico G; De Placido S; Bianco AR; Mendelsohn J; Tortora G
Clin Cancer Res; 2000 Sep; 6(9):3739-47. PubMed ID: 10999768
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of antisense oligodeoxynucleotide on expression of vascular endothelia growth factor by human hepatocarcinoma cells.
Qiu MB; Zhang JX; Liu LM; Gong BD; Wu BL; Zhu SS; Wen Y
Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):552-7. PubMed ID: 15567744
[TBL] [Abstract][Full Text] [Related]
18. Effect of antisense oligodeoxynucleotide of vascular endothelial growth factor C on lymphangiogenesis and angiogenesis of pancreatic cancer.
Li K; Tao J; Li T; Yu Z; Yang Z; Wu H; Xiong J; Wang C
J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):51-3. PubMed ID: 17393109
[TBL] [Abstract][Full Text] [Related]
19. Tgf-beta antisense therapy increases angiogenic potential in human keratinocytes in vitro.
Riedel K; Riedel F; Goessler UR; Germann G; Sauerbier M
Arch Med Res; 2007 Jan; 38(1):45-51. PubMed ID: 17174722
[TBL] [Abstract][Full Text] [Related]
20. Dynamic contrast-enhanced magnetic resonance imaging assessment of residual tumor angiogenesis after insufficient microwave ablation and donafenib adjuvant therapy.
Ren Z; Feng G; Li B; Zhang C; Du Y
Sci Rep; 2024 Feb; 14(1):4557. PubMed ID: 38402352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
